Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Donor immune cells attack metastatic breast cancer

03.06.2003


In patients with metastatic breast cancer, immune cells from a genetically matched donor can attack and shrink tumors, researchers from the National Cancer Institute (NCI) announced today at the Annual Meeting of the American Society of Clinical Oncology in Chicago. This is the first time researchers have clearly demonstrated this type of immune response, known as a graft-versus-tumor effect, acting against breast cancer.


"Graft-versus-tumor effects have been shown to be useful in treating cancers of the blood, such as leukemia and lymphoma. Breast cancer, however, has generally been resistant to immune-based therapies," said Michael Bishop, M.D., of NCI’s Center for Cancer Research, the lead author on the study. "Although the tumors of patients in this study were not completely eliminated by the treatment, the responses we saw provide hope that immunotherapies for breast cancer are worth pursuing."

Tumor regression has been observed in the past in some patients with metastatic breast cancer who received stem cell transplants, but it was unclear whether immune cells had attacked the tumor or the tumor was shrinking in response to chemotherapy drugs administered prior to the transplant. The design of this clinical trial, however, allowed researchers to attribute tumor regression to a true graft-versus-tumor effect.

Each of the 13 patients in the Phase I trial had received multiple previous treatments for metastatic breast cancer. In the study, patients first received conventional doses of chemotherapy to kill cancer cells and reduce the cells in their immune system so that donor cells could replace them. They then received stem cells from the blood of HLA-matched siblings. HLA-matched donor cells, which have the same set of proteins (known as human leukocyte-associated antigens) on their surface as the patient’s own cells, are much more likely to be accepted by the patient’s body.



T cells, specialized immune cells that recognize and kill foreign cells that have invaded the body, were removed from the pool of donated stem cells prior to transplant. These T cells were given to patients later, in an initial infusion 42 days after stem cell transplant, then in two follow-up infusions over the next two months. Because T cells were not given immediately following chemotherapy, researchers were able to attribute any tumor cell death to the transplanted T cells rather than to anti-tumor effects of the chemotherapy drugs.

In four patients, tumors shrunk at least 50 percent in response to the treatment. A minor response was seen in three of the other patients. Although not all patients in the study responded to treatment, and none of the tumors was eliminated entirely, the results of the trial provide evidence that transplanted T cells can attack tumors in patients with metastatic breast cancer. Researchers are optimistic that further study could lead to effective immunotherapies for these patients.

NCI Press Office | EurekAlert!
Further information:
http://www.cancer.gov

More articles from Health and Medicine:

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Taming 'wild' electrons in graphene

23.10.2017 | Physics and Astronomy

Mountain glaciers shrinking across the West

23.10.2017 | Earth Sciences

Scientists track ovarian cancers to site of origin: Fallopian tubes

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>